Hormonal
The metabolic syndrome is an imprecise and clinically unhelpful diagnostic construct for predicting cardiovascular disease risk because its definition is ambiguous, its underlying pathophysiology is uncertain, and it offers no predictive advantage over treating individual risk factors.
Do not wait for a 'metabolic syndrome' diagnosis to manage your heart health. If you have high blood pressure, high blood sugar, or abnormal cholesterol, treat those specific issues directly. The concept of 'metabolic syndrome' is too vague and does not add value to standard risk assessment. Focus on controlling your individual risk factors through lifestyle and medication as prescribed, rather than worrying about meeting a specific syndrome threshold.
Our analysis indicates that too much critically important information is missing to warrant its designation as a 'syndrome.' Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the 'metabolic syndrome.'
Why this rating
This is a joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, representing a high-level critical appraisal of existing literature.
Source
The Metabolic Syndrome: Time for a Critical Appraisal
Richard Kahn et al. · Diabetes Care · 2005
DOI 10.2337/diacare.28.9.2289
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →